Alkermes executives say they welcome any addiction treatment. PhotoThe Food and Drug Administration approved Vivitrol in 2006 for alcoholism and expanded its approved use to opioid addiction treatment in 2010, based on the Russian study. Alkermes assigns sales representatives to judges who oversee drug courts, where addicts arrested on minor drug charges go through supervised treatment programs. It made $222,521 in political contributions to Congress last year and has purchased high-level sponsorships of associations of drug court professionals and addiction treatment professionals, as well as organizations researching addiction treatment. It directs states to prioritize medication-assisted treatment for opioid addiction.

Source: New York Times June 11, 2017 13:17 UTC